10 Nov 2008 - Chemotargets to design the screening collection for the Universidade de Santiago de Compostela

Chemotargets and the Universidade de Santiago de Compostela (Galicia, Spain) have signed an agreement by which Chemotargets will use its methodology to select a focused set of ca. 10,000 compounds designed to provide maximum coverage across a panel of ca. 1200 targets from all main protein families of therapeutic relevance. This set of compounds will constitute the basis for a screening collection to be used by the BioFarma research group led by Dra. Mabel Loza in high-throughput screening campaigns in multiple projects.